
XOMA Corporation – NASDAQ:XOMAP
XOMA stock price today
XOMA stock price monthly change
XOMA stock price quarterly change
XOMA stock price yearly change
XOMA key metrics
Market Cap | 304.70M |
Enterprise value | 281.24M |
P/E | -10.09 |
EV/Sales | 13.01 |
EV/EBITDA | -6.84 |
Price/Sales | 14.08 |
Price/Book | 3.56 |
PEG ratio | 0.47 |
EPS | -3.44 |
Revenue | 5.81M |
EBITDA | -21.43M |
Income | -39.61M |
Revenue Q/Q | 240.96% |
Revenue Y/Y | 73.10% |
Profit margin | -138.67% |
Oper. margin | -136.09% |
Gross margin | 98.94% |
EBIT margin | -136.09% |
EBITDA margin | -368.92% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeXOMA stock price history
XOMA stock forecast
XOMA financial statements
Jun 2023 | 1.65M | -5.4M | -325.69% |
---|---|---|---|
Sep 2023 | 830K | -5.50M | -663.73% |
Dec 2023 | 1.83M | -20.10M | -1097.05% |
Mar 2024 | 1.49M | -8.59M | -576.85% |
Paying a dividend while loss making.
Payout ratio | -18.26% |
---|
2019 | |
---|---|
2020 | |
2021 | 1.18% |
2022 | 1.93% |
2023 | 1.88% |
Jun 2023 | 125661000 | 15.53M | 12.36% |
---|---|---|---|
Sep 2023 | 124094000 | 18.13M | 14.61% |
Dec 2023 | 234301000 | 145.58M | 62.13% |
Mar 2024 | 219420000 | 137.07M | 62.47% |
Jun 2023 | -7.20M | -4.48M | -1.16M |
---|---|---|---|
Sep 2023 | -2.09M | 5.49M | -1.36M |
Dec 2023 | -3.92M | 5.51M | 124.49M |
Mar 2024 | -5.52M | -7.24M | -4.37M |
XOMA alternative data
Aug 2023 | 11 |
---|---|
Sep 2023 | 11 |
Oct 2023 | 11 |
Nov 2023 | 11 |
Dec 2023 | 12 |
Jan 2024 | 12 |
Feb 2024 | 12 |
Mar 2024 | 13 |
Apr 2024 | 13 |
May 2024 | 13 |
Jun 2024 | 13 |
Jul 2024 | 13 |
XOMA other data
Period | Buy | Sel |
---|---|---|
Mar 2022 | 0 | 67950 |
Jul 2022 | 0 | 27000 |
Sep 2022 | 80951 | 0 |
Jan 2023 | 22249 | 0 |
Insider | Compensation |
---|---|
Mr. James R. Neal (1956) Chief Executive Officer & Chairman | $742,560 |
Mr. Thomas M. Burns (1974) Senior Vice President of Fin. & Chief Financial Officer | $495,380 |
-
What's the price of XOMA stock today?
One share of XOMA stock can currently be purchased for approximately $25.71.
-
When is XOMA's next earnings date?
Unfortunately, XOMA's (XOMAP) next earnings date is currently unknown.
-
Does XOMA pay dividends?
Yes, XOMA pays dividends and its trailing 12-month yield is 8.35% with -18% payout ratio.It means that the company is paying a dividend while loss making. The last XOMA stock dividend of $0.54 was paid on 17 Jan 2022.
-
How much money does XOMA make?
XOMA has a market capitalization of 304.70M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21.06% to 4.76M US dollars.
-
What is XOMA's stock symbol?
XOMA Corporation is traded on the NASDAQ under the ticker symbol "XOMAP".
-
What is XOMA's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of XOMA?
Shares of XOMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are XOMA's key executives?
XOMA's management team includes the following people:
- Mr. James R. Neal Chief Executive Officer & Chairman(age: 69, pay: $742,560)
- Mr. Thomas M. Burns Senior Vice President of Fin. & Chief Financial Officer(age: 51, pay: $495,380)
-
How many employees does XOMA have?
As Jul 2024, XOMA employs 13 workers.
-
When XOMA went public?
XOMA Corporation is publicly traded company for more then 4 years since IPO on 16 Dec 2020.
-
What is XOMA's official website?
The official website for XOMA is xoma.com.
-
Where are XOMA's headquarters?
XOMA is headquartered at 2200 Powell Street, EmeryVille, CA.
-
How can i contact XOMA?
XOMA's mailing address is 2200 Powell Street, EmeryVille, CA and company can be reached via phone at +51 02047200.
XOMA company profile:

XOMA Corporation
xoma.comNASDAQ
13
Biotechnology
Healthcare
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
EmeryVille, CA 94608
CIK: 0000791908
ISIN: US98419J3059
CUSIP: 98419J305